Recurrent Gastric Carcinoma

8 clinical trials · Condition

Record	Firm	Date
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations (NCT04550494)	National Cancer Institute (NCI)	2021-04-26
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients (NCT04213794)	Mayo Clinic	2019-11-08
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery (NCT03008278)	National Cancer Institute (NCI)	2018-02-06
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer (NCT03196232)	George Albert Fisher	2017-09-13
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060)	National Cancer Institute (NCI)	2015-08-17
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820)	Roswell Park Cancer Institute	2012-03-01
Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer (NCT01260701)	National Cancer Institute (NCI)	2011-01-01
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT01178944)	Roswell Park Cancer Institute	2010-09-01

Every clearance here is in the API, with alerts when new ones post.